Skip to content
An Initiative of AVAC
Search

Resource Library

The PrEPWatch Resource Database offers a wide range of material on the status of PrEP as an option for biomedical HIV prevention around the world. Search this database to find step-by-step guidance for rolling out PrEP, summaries of the research to date on safety, efficacy and implementation, tools to assist planning and roll out, country updates on PrEP policy and access, and lessons learned from those efforts.

Filter By
Multiple filters can be used at once

Showing results 111 - 120 of 169

Selected Filters:
7 July 2022

Consolidated guidelines on HIV prevention, testing, treatment, service delivery and monitoring: recommendations for a public health approach

These consolidated guidelines on HIV prevention, testing, treatment, service delivery and monitoring bring together existing and new clinical and programmatic recommendations across different ages, populations and settings, bringing together all relevant WHO guidance on HIV produced since 2016. It serves as an update to the previous edition of the consolidated guidelines on HIV.

Normative Guidance/Policies, Service Delivery

External Link
7 July 2022

WHO recommends the Dapivirine vaginal ring as a new choice for HIV prevention for women at substantial risk of HIV infection

This article announces the WHO's recommendation that the dapivirine vaginal ring may be offered as an additional prevention choice for women at substantial risk of HIV infection as part of combination prevention approaches.

Community/Advocacy, Normative Guidance/Policies

External Link
7 July 2022

Dapivirine Ring Advocacy Messaging Resource Package

The Dapivirine Vaginal Ring Advocacy Messaging Resource Package is a set of resources geared toward developing a messaging framework and implementation plan in support of PrEP Ring advocacy activities. Resources include the complete manual, the advocacy messaging framework template, FAQs, Ambassador toolkits, and a slide deck about the PrEP Ring.

Community/Advocacy, Demand Creation/Marketing

Document
7 July 2022

Put a ring on it: Four reasons to make the Dapivirine ring an HIV prevention option for women and girls

This article explains how the dapivirine vaginal ring can put the power of prevention directly in women's hands.

Community/Advocacy, Demand Creation/Marketing

External Link
7 July 2022

What Young Women Want

This letter comes from a group of young African women and reflects their HIV prevention research priorities. It was submitted to the National Institutes of Health’s (NIH) Division of AIDS (DAIDS) during the open-comment period concerning the structure and agenda for its next funding cycle (2021-2027).

Community/Advocacy

External Link
7 July 2022

InsidemyPurse.co.za

Inside My Purse is a blog which aims to create a supportive and informative space where adolescent girls and young women in sub-Saharan Africa can share and engage with content about sexual and reproductive health and rights, including HIV/AIDS and gender-based violence.

Community/Advocacy

External Link
7 July 2022

MTN-023/IPM 030 “iMatter”

Microbicide Trials Network-023/International Partnership for Microbicides 030 was a Phase 2a trial to assess safety of the dapivirine vaginal ring in HIV-uninfected adolescent females

Research, Service Delivery

External Link
7 July 2022

A Leap Forward For the Dapivirine Vaginal Ring, the Next Steps Are Critical

In this episode of Px Pulse, the Dapivirine Vaginal Ring is center stage. After decades of research and advocacy, the ring is now one step closer to becoming available as a discreet, woman-initiated HIV prevention option. In July the European Medicines Agency (EMA) issued a positive opinion for the ring, allowing the next steps in…

Community/Advocacy

External Link
7 July 2022

After The Ring Study: DREAM

DREAM, or Dapivirine Ring Extended Access and Monitoring, was a year long open-label extension (OLE) study launched by the International Partnership for Microbicides (IPM) in 2019 to assess how safe the ring is for the 940 HIV- women who participated in The Ring Study, and explores when, why, and how women use the ring.

Community/Advocacy

External Link
7 July 2022

Safety, Adherence and HIV-1 Seroconversion in DREAM – An Open-label Dapivirine Vaginal Ring Trial

The Ring Study, a phase 3 trial in 1959 sexually active women (randomised 2:1), showed a favourable safety profile and a 31% HIV-1 infection risk reduction for a vaginal ring containing 25 mg of dapivirine, compared with a placebo ring. This article features a report on the DREAM study, which aimed to evaluate safety, adherence,…

Research

Document